3.76
price down icon3.59%   -0.14
after-market Handel nachbörslich: 3.85 0.09 +2.39%
loading

Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.089
- 2.379 3.812 1.195
Interest Income/Expense
0.111
- - - -
Operating Income/Loss
-3.089
- -2.379 -3.812 -1.195
Nonoperating Income/Loss
-0.031
- 0.007 0.034 0.063
Income/Loss From Continuing Operations Before Tax
3.14%
-3.12
-3.221 -2.372 -15.87 -1.132
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
3.14%
-3.12
-3.221 -2.372 -15.87 -1.132
Net Income/Loss
3.14%
-3.12
-3.221 -2.372 -15.87 -1.132
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - -12.10 -
Diluted Average Shares
0.787
- 3.281 0.01 3.228
Diluted Earnings Per Share
-3.97
- -0.72 -1.17 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):